{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:43:23Z","timestamp":1794321803980,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sarcoidosis patients exhibit an elevated risk of developing lung cancer (LC), suggesting shared genetic and molecular mechanisms between these conditions. This study aimed to identify common differentially expressed genes (DEGs) in sarcoidosis and LC and to evaluate the therapeutic potential of a repurposable drug targeting these shared genes. Gene expression datasets (GSE157671 and GSE229253) were analyzed to identify overlapping DEGs, with validation performed using additional GEO datasets and the GEPIA tool. Functional enrichment and protein\u2013protein interaction (PPI) analyses were conducted using Enrichr and STRING, while associated miRNAs and transcription factors were identified via miRNet. Twelve DEGs\u2014<jats:italic>SALL4<\/jats:italic>, <jats:italic>WNT10A<\/jats:italic>, <jats:italic>RASAL1<\/jats:italic>, <jats:italic>CAMK2B<\/jats:italic>, <jats:italic>GADD45B<\/jats:italic>, <jats:italic>KLF4<\/jats:italic>, <jats:italic>OLR1<\/jats:italic>, <jats:italic>CSF3<\/jats:italic>, <jats:italic>WIF1<\/jats:italic>, <jats:italic>RAMP3<\/jats:italic>, <jats:italic>AGER<\/jats:italic>, and <jats:italic>PRKAG3<\/jats:italic>\u2014were consistently dysregulated in both diseases. These genes were significantly associated with epithelial cell enrichment and the Wnt signaling pathway. Drug\u2013gene interaction analysis using DGIdb prioritized metformin as a candidate drug targeting PRKAG3. Its structural integrity was confirmed via X-ray diffraction (XRD) and Rietveld refinement. In vitro validation using MTT assays revealed that metformin selectively reduced viability in A549 (adenocarcinoma human alveolar basal epithelial cells) and HeLa (a widely used epithelial cancer cell line), with minimal cytotoxicity in WI38 normal lung fibroblasts. Colony formation assays further demonstrated dose-dependent, long-term growth inhibition in cancer cells, corroborated by observable morphological alterations. Overall, this study highlights shared pathogenic signatures between sarcoidosis and LC and proposes metformin as a promising therapeutic candidate. These findings support the rationale for drug repurposing and the development of targeted therapies for patients with overlapping disease profiles or those at increased risk of LC progression from sarcoidosis.<\/jats:p>","DOI":"10.1186\/s41065-025-00503-7","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T05:11:20Z","timestamp":1754975480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic overlap between sarcoidosis and lung cancer: a combined in silico and in vitro approach"],"prefix":"10.1186","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9085-2658","authenticated-orcid":false,"given":"Sanjukta","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moupiya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhendu","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26\u201351. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"503_CR2","doi-asserted-by":"publisher","unstructured":"Kobayashi N, Nakamura R, Kurishima K, et al (2010) Sarcoidosis and lung cancer. Acta Medica (Hradec Kralove) 53:115\u2013118. https:\/\/doi.org\/10.14712\/18059694.2016.69","DOI":"10.14712\/18059694.2016.69"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1378\/chest.14-1475","volume":"147","author":"M Bonifazi","year":"2015","unstructured":"Bonifazi M, Bravi F, Gasparini S, et al. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest. 2015;147:778\u201391. https:\/\/doi.org\/10.1378\/chest.14-1475.","journal-title":"Chest"},{"issue":"9","key":"503_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45508","volume":"15","author":"L Umeano","year":"2023","unstructured":"Umeano L, Pujari HP, Nasiri SMZJ, et al. The association between lung cancer and sarcoidosis: A literature review. Cureus. 2023;15(9): e45508. https:\/\/doi.org\/10.7759\/cureus.45508.","journal-title":"Cureus"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acr.22941","volume":"69","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Risk of malignancy among patients with sarcoidosis: a population-based cohort study. Arthritis Care Res. 2017;69:46\u201350. https:\/\/doi.org\/10.1002\/acr.22941.","journal-title":"Arthritis Care Res"},{"key":"503_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.755222","volume":"12","author":"F Alqutami","year":"2021","unstructured":"Alqutami F, Senok A, Hachim M. COVID-19 transcriptomic atlas: A comprehensive analysis of COVID-19 related transcriptomics datasets. Front Genet. 2021;12: 755222. https:\/\/doi.org\/10.3389\/fgene.2021.755222.","journal-title":"Front Genet"},{"issue":"10","key":"503_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/omi.2024.0150","volume":"28","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S. Systems biology and machine learning identify genetic overlaps between lung cancer and gastroesophageal reflux disease. OMICS. 2024;28(10):492\u2013503. https:\/\/doi.org\/10.1089\/omi.2024.0150.","journal-title":"OMICS"},{"key":"503_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.697157","volume":"12","author":"N Li","year":"2021","unstructured":"Li N, Li L, Wu M, et al. Integrated bioinformatics and validation reveal potential biomarkers associated with progression of primary sj\u00f6gren\u2019s syndrome. Front Immunol. 2021;12: 697157. https:\/\/doi.org\/10.3389\/fimmu.2021.697157.","journal-title":"Front Immunol"},{"key":"503_CR9","doi-asserted-by":"publisher","first-page":"1275064","DOI":"10.3389\/fimmu.2024.1275064","volume":"15","author":"S Wu","year":"2024","unstructured":"Wu S, Liu M, Zhang M, et al. The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis. Front Immunol. 2024;15:1275064. https:\/\/doi.org\/10.3389\/fimmu.2024.1275064.","journal-title":"Front Immunol"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"1121257","DOI":"10.3389\/fmed.2023.1121257","volume":"10","author":"KM Liao","year":"2023","unstructured":"Liao KM, Lee CS, Wu YC, et al. Prior treated tuberculosis and mortality risk in lung cancer. Front Med. 2023;10:1121257. https:\/\/doi.org\/10.3389\/fmed.2023.1121257.","journal-title":"Front Med"},{"issue":"1","key":"503_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13027-022-00434-2","volume":"17","author":"Y Qin","year":"2022","unstructured":"Qin Y, Chen Y, Chen J, et al. The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future. Infect Agent Cancer. 2022;17(1):20. https:\/\/doi.org\/10.1186\/s13027-022-00434-2.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"503_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/resp.13482","volume":"24","author":"SH Wang","year":"2019","unstructured":"Wang SH, Chung CH, Huang TW, et al. Bidirectional association between tuberculosis and sarcoidosis. Respirology. 2019;24(5):467\u201374. https:\/\/doi.org\/10.1111\/resp.13482.","journal-title":"Respirology"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12931-020-01537-3","volume":"21","author":"NG Casanova","year":"2020","unstructured":"Casanova NG, Gonzalez-Garay ML, Sun B, et al. Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomas. Respir Res. 2020;21:321. https:\/\/doi.org\/10.1186\/s12931-020-01537-3.","journal-title":"Respir Res"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"1012827","DOI":"10.3389\/fmed.2022.1012827","volume":"9","author":"NG Casanova","year":"2022","unstructured":"Casanova NG, Reyes-Hernon V, Gregory T, et al. Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2. Front Med. 2022;9:1012827. https:\/\/doi.org\/10.3389\/fmed.2022.1012827.","journal-title":"Front Med"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1038\/s41467-023-42327-x","volume":"14","author":"I Dolgalev","year":"2023","unstructured":"Dolgalev I, Zhou H, Murrell N, et al. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma. Nat Commun. 2023;14:6764. https:\/\/doi.org\/10.1038\/s41467-023-42327-x.","journal-title":"Nat Commun"},{"key":"503_CR16","doi-asserted-by":"publisher","unstructured":"Dasgupta S, Ghosh S. (2024) Identification of overlapping molecular mechanisms in tuberculosis and sarcoidosis: A bioinformatics approach. Human Gene. 2024 ;42:201329. https:\/\/doi.org\/10.1016\/j.humgen.2024.201329","DOI":"10.1016\/j.humgen.2024.201329"},{"issue":"10","key":"503_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1164\/rccm.201106-1143OC","volume":"184","author":"LL Koth","year":"2011","unstructured":"Koth LL, Solberg OD, Peng JC, Bhakta NR, et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med. 2011;184(10):1153\u201363. https:\/\/doi.org\/10.1164\/rccm.201106-1143OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"503_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1183\/09031936.00039714","volume":"44","author":"R Su","year":"2014","unstructured":"Su R, Li MM, Bhakta NR, Solberg OD, et al. Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J. 2014;44(4):985\u201393. https:\/\/doi.org\/10.1183\/09031936.00039714.","journal-title":"Eur Respir J"},{"issue":"12","key":"503_CR19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.202012-4423OC","volume":"204","author":"L Bauer","year":"2021","unstructured":"Bauer L, M\u00fcller LJ, Volkers SM, Heinrich F, et al. Follicular helper-like T cells in the lung highlight a novel role of B cells in sarcoidosis. Am J Respir Crit Care Med. 2021;204(12):1403\u201317. https:\/\/doi.org\/10.1164\/rccm.202012-4423OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"503_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.822094","volume":"9","author":"K Yoshioka","year":"2022","unstructured":"Yoshioka K, Sato H, Kawasaki T, Ishii D, et al. Transcriptome analysis of peripheral blood mononuclear cells in pulmonary sarcoidosis. Front Med. 2022;9: 822094. https:\/\/doi.org\/10.3389\/fmed.2022.822094.","journal-title":"Front Med"},{"issue":"2","key":"503_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ijc.25704","volume":"129","author":"A Sanchez-Palencia","year":"2011","unstructured":"Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, et al. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer. 2011;129(2):355\u201364. https:\/\/doi.org\/10.1002\/ijc.25704.","journal-title":"Int J Cancer"},{"key":"503_CR22","doi-asserted-by":"publisher","unstructured":"Kuo CS, Liu CY, Pavlidis S, Lo YL et al (2018) Unique immune gene expression patterns in bronchoalveolar lavage and tumor adjacent non-neoplastic lung tissue in non-small cell lung cancer. Front Immunol 2018;9:232. https:\/\/doi.org\/10.3389\/fimmu.2018.00232","DOI":"10.3389\/fimmu.2018.00232"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","journal-title":"Nucleic Acids Res"},{"key":"503_CR24","doi-asserted-by":"publisher","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky A, Gy\u0151rffy B. Web-based survival analysis tool tailored for medical research (KMplot): Development and implementation. J Med Internet Res. 2021;23: e27633. https:\/\/doi.org\/10.2196\/27633.","journal-title":"J Med Internet Res"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60\u20134. https:\/\/doi.org\/10.1093\/nar\/gky311.","journal-title":"Nucleic Acids Res"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362\u20138. https:\/\/doi.org\/10.1093\/nar\/gkw937.","journal-title":"Nucleic Acids Res"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48:W244\u201351. https:\/\/doi.org\/10.1093\/nar\/gkaa467.","journal-title":"Nucleic Acids Res"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137. https:\/\/doi.org\/10.1093\/nar\/gkw377.","journal-title":"Nucleic Acids Res"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"W782","DOI":"10.1093\/nar\/gkac392","volume":"50","author":"Y Dai","year":"2022","unstructured":"Dai Y, Hu R, Liu A, et al. WebCSEA: web-based cell-type-specific enrichment analysis of genes. Nucleic Acids Res. 2022;50:W782\u201390. https:\/\/doi.org\/10.1093\/nar\/gkac392.","journal-title":"Nucleic Acids Res"},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"D1036","DOI":"10.1093\/nar\/gkv1165","volume":"44","author":"AH Wagner","year":"2016","unstructured":"Wagner AH, Coffman AC, Ainscough BJ, et al. DGIdb 2.0: mining clinically relevant drug-gene interactions. Nucleic Acids Res. 2016;44:D1036\u201344. https:\/\/doi.org\/10.1093\/nar\/gkv1165.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"503_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/omi.2024.0213","volume":"29","author":"S Dasgupta","year":"2025","unstructured":"Dasgupta S. Idiopathic Pulmonary Fibrosis: In silico therapeutic potential of doxycycline, pirfenidone, and nintedanib, and the role of next-generation phenomics in drug discovery. OMICS. 2025;29(3):87\u201395. https:\/\/doi.org\/10.1089\/omi.2024.0213.","journal-title":"OMICS"},{"key":"503_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104781","volume":"87","author":"M Ghosh","year":"2023","unstructured":"Ghosh M, Mandal S, Paul S, Chakrabarty S, et al. Synthesis and characterization of metformin conjugated magnetic nanocomposite with enhanced activity against the human carcinoma cells. J Drug Deliv Sci Technol. 2023;87: 104781. https:\/\/doi.org\/10.1016\/j.jddst.2023.104781.","journal-title":"J Drug Deliv Sci Technol"},{"key":"503_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103549","volume":"74","author":"M Ghosh","year":"2022","unstructured":"Ghosh M, Pradhan S, Mandal S, et al. Enhanced antibacterial activity of a novel protein-arginine deiminase type-4 (PADI4) inhibitor after conjugation with a biocompatible nanocarrier. J Drug Deliv Sci Technol. 2022;74: 103549. https:\/\/doi.org\/10.1016\/j.jddst.2022.103549.","journal-title":"J Drug Deliv Sci Technol"},{"key":"503_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107658","volume":"227","author":"P Choudhury","year":"2024","unstructured":"Choudhury P, Dasgupta S, Kar A, Sarkar S, Chakraborty P, Bhattacharyya P, Roychowdhury S, Chaudhury K. Bioinformatics analysis of hypoxia-associated genes and inflammatory cytokine profiling in COPD-PH. Respir Med. 2024;227: 107658. https:\/\/doi.org\/10.1016\/j.rmed.2024.107658.","journal-title":"Respir Med"},{"issue":"5","key":"503_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11306-023-02012-y","volume":"19","author":"S Dasgupta","year":"2023","unstructured":"Dasgupta S, Subramani E, Mitra I, Bhattacharya A, Sherpa DD, Joshi M, Chakraborty P, Ray CD, Chaudhury K. Discovery of novel metabolic signatures for early identification of women at risk of developing gestational hypertension. Metabolomics. 2023;19(5):50. https:\/\/doi.org\/10.1007\/s11306-023-02012-y.","journal-title":"Metabolomics"},{"issue":"4","key":"503_CR36","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/ijms23042053","volume":"23","author":"B Sun","year":"2022","unstructured":"Sun B, Xu L, Bi W, Ou WB. SALL4 oncogenic function in cancers: mechanisms and therapeutic relevance. Int J Mol Sci. 2022;23(4):2053. https:\/\/doi.org\/10.3390\/ijms23042053.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"503_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12032-024-02344-2","volume":"41","author":"RA Gatenby","year":"2024","unstructured":"Gatenby RA, Luddy KA, Teer JK, et al. Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways. Med Oncol. 2024;41(6):135. https:\/\/doi.org\/10.1007\/s12032-024-02344-2.","journal-title":"Med Oncol"},{"key":"503_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.600243","volume":"11","author":"TW Miao","year":"2021","unstructured":"Miao TW, Du LY, Xiao W, et al. Identification of survival-associated gene signature in lung cancer coexisting with COPD. Front Oncol. 2021;11: 600243. https:\/\/doi.org\/10.3389\/fonc.2021.600243.","journal-title":"Front Oncol"},{"key":"503_CR39","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1186\/s12879-024-08731-w","volume":"24","author":"Z Liu","year":"2024","unstructured":"Liu Z, Petinrin OO, Chen N, et al. Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells. BMC Infect Dis. 2024;24:1099. https:\/\/doi.org\/10.1186\/s12879-024-08731-w.","journal-title":"BMC Infect Dis"},{"key":"503_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121413","volume":"316","author":"Z Liu","year":"2023","unstructured":"Liu Z, Georgakopoulos-Soares I, Ahituv N, et al. Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights. Life Sci. 2023;316: 121413. https:\/\/doi.org\/10.1016\/j.lfs.2023.121413.","journal-title":"Life Sci"},{"issue":"6","key":"503_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41419-020-2553-6","volume":"11","author":"SQ Wang","year":"2020","unstructured":"Wang SQ, Liu J, Qin J, et al. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation. Cell Death Dis. 2020;11(6):410. https:\/\/doi.org\/10.1038\/s41419-020-2553-6.","journal-title":"Cell Death Dis"},{"key":"503_CR42","doi-asserted-by":"publisher","unstructured":"Benard EL, Hammerschmidt M (2025) The fundamentals of WNT10A. Differentiation 100838. https:\/\/doi.org\/10.1016\/j.diff.2025.100838","DOI":"10.1016\/j.diff.2025.100838"},{"key":"503_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1439-0388.2005.00545.x","volume":"122","author":"SL Yu","year":"2005","unstructured":"Yu SL, Kim JE, Chung HJ, et al. Molecular cloning and characterization of bovine PRKAG3 gene: structure, expression and single nucleotide polymorphism detection. J Anim Breed Genet. 2005;122:294\u2013301. https:\/\/doi.org\/10.1111\/j.1439-0388.2005.00545.x.","journal-title":"J Anim Breed Genet"},{"issue":"2","key":"503_CR44","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3892\/mmr.2020.11176","volume":"22","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhu W, Xiao G, et al. Effect of AGER on the biological behavior of non small cell lung cancer H1299 cells. Mol Med Rep. 2020;22(2):810\u20138. https:\/\/doi.org\/10.3892\/mmr.2020.11176.","journal-title":"Mol Med Rep"},{"key":"503_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-94804-7_1","volume":"1360","author":"A Humayun","year":"2022","unstructured":"Humayun A, Fornace AJ Jr. GADD45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol. 2022;1360:1\u201322. https:\/\/doi.org\/10.1007\/978-3-030-94804-7_1.","journal-title":"Adv Exp Med Biol"},{"key":"503_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200765","volume":"32","author":"T Oda","year":"2024","unstructured":"Oda T, Tsutsumi K, Obata T, et al. MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer. Molecular therapy Oncology. 2024;32: 200765. https:\/\/doi.org\/10.1016\/j.omton.2024.200765.","journal-title":"Molecular therapy Oncology"},{"key":"503_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khoshbakht T, Hussen BM, et al. A review on the role of mir-16-5p in the carcinogenesis. Cancer Cell Int. 2022;22:342. https:\/\/doi.org\/10.1186\/s12935-022-02754-0.","journal-title":"Cancer Cell Int"},{"key":"503_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86. https:\/\/doi.org\/10.1186\/1476-4598-12-86.","journal-title":"Mol Cancer"},{"issue":"1\u20132","key":"503_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mrfmmm.2009.09.009","volume":"690","author":"H Martin","year":"2010","unstructured":"Martin H. Role of PPAR-gamma in inflammation: Prospects for therapeutic intervention by food components. Mutat Res. 2010;690(1\u20132):57\u201363. https:\/\/doi.org\/10.1016\/j.mrfmmm.2009.09.009.","journal-title":"Mutat Res"},{"key":"503_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2015.12.018","volume":"104","author":"R Herro","year":"2016","unstructured":"Herro R, Croft M. The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF superfamily member 14). Pharmacol Res. 2016;104:151\u20135. https:\/\/doi.org\/10.1016\/j.phrs.2015.12.018.","journal-title":"Pharmacol Res"},{"issue":"5","key":"503_CR51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007.","journal-title":"Cell"},{"key":"503_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6.","journal-title":"Signal Transduct Target Ther"},{"key":"503_CR53","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1111\/jcmm.16445","volume":"25","author":"N Li","year":"2021","unstructured":"Li N, Ouyang Y, Xu X, et al. MiR-155 promotes colitis-associated intestinal fibrosis by targeting HBP1\/Wnt\/\u03b2-catenin signalling pathway. J Cell Mol Med. 2021;25:4765\u201375. https:\/\/doi.org\/10.1111\/jcmm.16445.","journal-title":"J Cell Mol Med"},{"key":"503_CR54","doi-asserted-by":"publisher","unstructured":"Tang ZY, Sheng MJ, Qi YX, Wang LY, He DY (2018) Metformin enhances inhibitive effects of carboplatin on HeLa cell proliferation and increases sensitivity to carboplatin by activating mitochondrial-associated apoptosis signaling pathway. Eur Rev Med Pharmacol Sci 22:8104\u20138112. 8104\u20138112. https:\/\/doi.org\/10.26355\/eurrev_201812_16501.","DOI":"10.26355\/eurrev_201812_16501"},{"issue":"17","key":"503_CR55","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3390\/cells12172182","volume":"12","author":"D Conza","year":"2023","unstructured":"Conza D, Mirra P, Fiory F, et al. Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer. Cells. 2023;12(17):2182. https:\/\/doi.org\/10.3390\/cells12172182.","journal-title":"Cells"},{"key":"503_CR56","doi-asserted-by":"publisher","first-page":"1445923","DOI":"10.3389\/fphar.2024.1445923","volume":"15","author":"K B\u0105czek","year":"2024","unstructured":"B\u0105czek K, Piotrowski WJ. Lung fibrosis in sarcoidosis: Is there a place for antifibrotics? Front Pharmacol. 2024;15:1445923. https:\/\/doi.org\/10.3389\/fphar.2024.1445923.","journal-title":"Front Pharmacol"},{"issue":"3","key":"503_CR57","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3892\/ol.2019.9892","volume":"17","author":"SY Park","year":"2019","unstructured":"Park SY, Kim D, Kee SH. Metformin-activated AMPK regulates \u03b2-catenin to reduce cell proliferation in colon carcinoma RKO cells. Oncol Lett. 2019;17(3):2695\u2013702. https:\/\/doi.org\/10.3892\/ol.2019.9892.","journal-title":"Oncol Lett"},{"issue":"4","key":"503_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/jcpt.13167","volume":"45","author":"K Xiao","year":"2020","unstructured":"Xiao K, Liu F, Liu J, Xu J, Wu Q, Li X. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. J Clin Pharm Ther. 2020;45(4):783\u201392. https:\/\/doi.org\/10.1111\/jcpt.13167.","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"503_CR59","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4252\/wjsc.v12.i12.1455","volume":"12","author":"LL Jiang","year":"2020","unstructured":"Jiang LL, Liu L. Effect of metformin on stem cells: Molecular mechanism and clinical prospect. World J Stem Cells. 2020;12(12):1455\u201373. https:\/\/doi.org\/10.4252\/wjsc.v12.i12.1455.","journal-title":"World J Stem Cells"},{"key":"503_CR60","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.7150\/jca.58780","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Zhou C, Yi J, et al. Metformin and arsenic trioxide synergize to trigger Parkin\/PINK1-dependent mitophagic cell death in human cervical cancer HeLa cells. J Cancer. 2021;12:6310\u20139. https:\/\/doi.org\/10.7150\/jca.58780.","journal-title":"J Cancer"},{"key":"503_CR61","doi-asserted-by":"publisher","unstructured":"Chu Z, Tan Y, Xu C, Zhangsun D, Zhu X (2023) Potential mechanisms of metformin-induced apoptosis in HeLa cells. Cancer Cell Int 13. https:\/\/doi.org\/10.1186\/s12935-023-02054-1","DOI":"10.1186\/s12935-023-02054-1"},{"key":"503_CR62","doi-asserted-by":"publisher","unstructured":"Morelli AP, Tortelli TC Jr, Pavan ICB, et al (2021) Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways. Int J Oncol 58. https:\/\/doi.org\/10.3892\/ijo.2021.5193","DOI":"10.3892\/ijo.2021.5193"},{"key":"503_CR63","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/toxres\/tfad053","volume":"12","author":"F Motafeghi","year":"2023","unstructured":"Motafeghi F, Shahsavari R, Mortazavi P, et al. Metformin and aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action. Toxicol Res. 2023;12:702\u20138. https:\/\/doi.org\/10.1093\/toxres\/tfad053.","journal-title":"Toxicol Res"},{"key":"503_CR64","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1007\/s12011-023-03721-4","volume":"202","author":"A Ye\u015filda\u011f","year":"2024","unstructured":"Ye\u015filda\u011f A, K\u0131z\u0131lo\u011flu HT, Dirican E, et al. Anticarcinogenic effects of gold nanoparticles and metformin against MCF-7 and A549 cells. Biol Trace Elem Res. 2024;202:4494\u2013507. https:\/\/doi.org\/10.1007\/s12011-023-03721-4.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"503_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.2910170110","volume":"17","author":"M Lieber","year":"1976","unstructured":"Lieber M, Smith B, Szakal A, et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17(1):62\u201370. https:\/\/doi.org\/10.1002\/ijc.2910170110.","journal-title":"Int J Cancer"},{"key":"503_CR66","doi-asserted-by":"crossref","unstructured":"Bisig C, Voss C, Petri-Fink A, Rothen-Rutishauser B. The crux of positive controls - Pro-inflammatory responses in lung cell models. Toxicol In Vitro. 2019 Feb;54:189\u2013193. https:\/\/doi.org\/10.1016\/j.tiv.2018.09.021\n. Epub 2018 Oct 2. Erratum in: Toxicol In Vitro. 2020 Jun;65:104751. https:\/\/doi.org\/10.1016\/j.tiv.2019.104751\n. PMID: 30290203.","DOI":"10.1016\/j.tiv.2019.104751"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00503-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T05:11:22Z","timestamp":1754975482000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00503-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00503-7","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}